心房动:关于诊断和治疗的常见问题和答案
1AtlantiCare Regional Medical Center Family Medicine Residency Program, Atlantic City, New Jersey.
American family physician
|May 28, 2024
概括
心房动是一种常见的心律障碍,增加了中风风险. 目前的指南缺乏对50岁以上成年人查的证据,但诊断和管理对于预防并发症至关重要.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 预防性心脏病学 预防性心脏病学
背景情况:
- 心房动是成年人中最常见的心律失常症,增加中风和死亡风险.
- 患病率随着年龄的增长而升级,但对50岁以上无症状个体进行查缺乏足够的证据.
- 症状可能不存在或包括心,呼吸不良,疲劳和胸痛.
研究的目的:
- 总结目前对心房的理解和管理策略.
- 突出诊断标准和初始评估协议.
- 概述治疗方法,重点是降低中风风险,控制速率和节律控制.
主要方法:
- 诊断依赖于患者病史,体检和心电图确认.
- 最初的评估包括心声回声,血液测试 (电解质,CBC,甲状腺,脏,肝功能).
- 脑卒中风险分层使用CHA2DS2-VASc得分.
主要成果:
- 使用华法林或直接口服抗凝剂的抗凝剂显著降低了中风风险.
- 血液动力学不稳定的患者需要紧急评估和治疗.
- 大多数稳定的患者从初始速率控制和抗凝药中受益.
结论:
- 节律控制策略,包括电动心脏转换或导管切除,是特定患者群体的选择.
- 共享决策是节律控制选择的关键.
- 有效的管理涉及抗凝剂,速率控制和适当时节律控制的组合.
相关概念视频
Disturbances in Heart Rhythm
936
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
936
Mechanism of Cardiac Arrhythmias
912
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
912
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
211
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
211
Increased pulse rate
652
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
652
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
157
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157


